API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. LSE /
  3. 0MTD.LSE

Swedish Orphan Biovitrum AB (0MTD LSE) stock market data APIs

kr327.4 0(0%) as of September 18, 2024
Price chart is built with Anychart

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. It offers Alprolix for haemophilia B; Aspaveli®/Empaveli for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); VONJO for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis; Zynlonta, an aggressive malignant disease; Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company also provides other products, such as Akynzeo, Tegsedi, Jyseleca, Kepivance, Aloxi, and Waylivra. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Sanofi, Apellis Pharmaceuticals Inc., ADC Therapeutics SA, and Cartesian Therapeutics, Inc. Swedish Orphan Biovitrum AB (publ) was incorporated in 1939 and is headquartered in Solna, Sweden.

Swedish Orphan Biovitrum AB Financial Data Overview

327.4
327.4
-
327.4
309.8
206.2-338
57 338 M
0
23 710 M
0.6497
0.228
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '0MTD',
Type: 'Common Stock',
Name: 'Swedish Orphan Biovitrum AB',
Exchange: 'LSE',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'UK',
CountryISO: 'GB',
OpenFigi: NULL,
ISIN: 'SE0000872095',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: '',
Industry: '',
}

Swedish Orphan Biovitrum AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 23 710 M
  • EBITDA 8 034 M
  • Earnings Per Share
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Swedish Orphan Biovitrum AB Earnings via APIs

  • Latest Release 2024-07-16
  • EPS/Forecast NaN

Get Swedish Orphan Biovitrum AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Swedish Orphan Biovitrum AB latest news via APIs

High Growth Tech Stocks In Sweden Embracer Group And Two More

Sweden's tech sector has been gaining attention amid a backdrop of strong performance in global growth stocks, with technology shares outpacing their value counterparts significantly. As markets navig...

Exploring 3 High Growth Tech Stocks In Sweden

Sweden's tech market has shown resilience and potential for high growth, particularly as global markets rebound from recent sell-offs and the European Central Bank cuts rates to stimulate economic act...
Do you have any questions?
support@eodhistoricaldata.com